Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or Attention-Deficit/Hyperactivity Disorder Among Sibling-Matched Cohorts.

JAMA internal medicine·2026

Same author

Association of Reduction in Continuity of Care During COVID-19 Pandemic With Cardiovascular Diseases, Kidney Failure and All-Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong.

Diabetes, obesity & metabolism·2026

Same author

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026

Same author

The optimal blood pressure target in old and very old patients with hypertension.

Age and ageing·2026

Same author

Optimal blood pressure target in patients with uncomplicated hypertension: a target trial emulation study.

Nature communications·2026

Same author

Evaluating the Clinical and Humanistic Impact of a Self-Care and Minor Ailment Service (MAS).

Communications medicine·2026

Same journal

Organisational culture: variation across hospitals and connection to patient safety climate.

Quality & safety in health care·2010

Same journal

The Rhode Island ICU collaborative: a model for reducing central line-associated bloodstream infection and ventilator-associated pneumonia statewide.

Quality & safety in health care·2010

Same journal

Assessing and improving safety culture throughout an academic medical centre: a prospective cohort study.

Quality & safety in health care·2010

Same journal

The WHO patient safety curriculum guide for medical schools.

Quality & safety in health care·2010

Same journal

Preventing ethics conflicts and improving healthcare quality through system redesign.

Quality & safety in health care·2010

Same journal

Improvement leaders: what do they and should they do? A summary of a review of research.

Quality & safety in health care·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Paediatric dosing errors before and after electronic prescribing.

Yogini Hariprasad Jani¹, Nick Barber, Ian Chi Kei Wong

¹Centre for Paediatric Pharmacy Research, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK. yogini.jani@pharmacy.ac.uk

Quality & Safety in Health Care

|August 10, 2010

Summary

This summary is machine-generated.

Implementing electronic prescribing (EP) significantly reduced dosing errors in pediatric care. While the overall rate of errors decreased, further research is needed to fully understand the impact on error severity.

More Related Videos

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Experiment Videos

Last Updated: Jun 10, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Pediatric pharmacology
Health informatics
Medication safety

Background:

Dose prescribing errors pose a significant risk in pediatric healthcare.
Electronic prescribing systems aim to mitigate medication errors.

Purpose of the Study:

To evaluate the impact of an electronic prescribing system on the incidence and severity of dose prescribing errors in a pediatric hospital.

Main Methods:

Prescription review was used to identify dose errors.
A validated scoring tool and expert judges assessed error severity.
Data was compared pre- and post-implementation of the electronic prescribing system.

Main Results:

The incidence of dose prescribing errors decreased from 2.2% to 1.2% after implementing electronic prescribing (p<0.001).
A statistically significant reduction was observed in errors with potentially minor (p=0.009) and moderate (p=0.019) outcomes.
While a trend towards reduced severe outcomes was noted, it did not reach statistical significance (p=0.11).

Conclusions:

Electronic prescribing shows promise in reducing dosing error rates in pediatric settings.
Larger studies are necessary to confirm the effect on error severity and generalizability across different healthcare environments.